Tau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment
None
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2011
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/19810 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Tau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment
- Inhibition of Tau Phosphorylation as a Potential Strategy in Treatment of Parkinson’s Disease
- Phosphorylation of Tau Protein Associated as a Protective Mechanism in the Presence of Toxic, C-Terminally Truncated Tau in Alzheimer's Disease
- Traditional and Modern Medicine Harmonizing the Two Approaches in the Treatment of Neurodegeneration (Alzheimer’s Disease – AD)
- Tau in Health and Neurodegenerative Diseases
- Pathological Stages of Abnormally Processed Tau Protein During Its Aggregation into Fibrillary Structures in Alzheimer’s Disease
- Progressive Neurodegeneration of Retina in Alzheimer’s Disease — Are β-Amyloid Peptide and Tau New Pathological Factors in Glaucoma?